Press Release

View all news

Nano Dimension Announced Q3 2022 Revenue of $10M & Record Backlog

12/01/2022

646% Higher over Q3 Last Year
964% Higher YTD 2022 vs. Same Period 2021

Conference call to be held today at 9:00 a.m. EDT

WALTHAM, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), an industry leader in Additively Manufactured Electronics, additive PCB assembly & printhead drivers and software (AME), and a supplier of Additive Manufacturing machines and materials (AM), today announced financial results for the third quarter ended September 30th, 2022. 

Nano Dimension reported revenues of $10M for the third quarter of 2022, an increase of 646% over the same quarter in 2021 and 10% less than Q2/2022. Moreover, the 3rd quarter of 2022 revenue run-rate indicates the potential for growth of approximately 300% in full year 2022 over 2021. If this occurs, the Company’s revenue will be growing over 10 times from 2020 to 2022, assuming no critical changes in the world economy resulting from current international affairs and/or other factors.

Revenues for the nine months period ended September 30th, 2022, were $31.5M, which represent a 964% increase over the nine months period ended September 30th, 2021.

Total loss before tax for the 3rd quarter of 2022 was $67.1M.

  • Adjusted EBITDA for the 3rd quarter of 2022 was negative $24.2M, excluding $42.9M of non-cash adjustments for finance expenses/income for revaluation of assets and liabilities, share-based payments, exchange rate differences, interest income and depreciation and amortization expenses.
  • Adjusted EBITDA as above includes R&D cash expenses of $13.5M.
  • Net cash used in operations during the 3rd quarter of 2022 was $22.3M.

Details regarding EBITDA and Adjusted EBITDA can be found later in this press release under “Non-IFRS measures.”

Yoav Stern, Chairman & CEO, comments: “The comparable increases of revenue of Q3 2022 over Q3 2021 (646%) and year-to-date over last-year-year-to-date (964%) - highlight the business’ continued success in growing dramatically, better than our expectations as expressed last year. We also finished the third quarter with a record backlog of approximately $9M.

All our product lines’ revenue grew organically exceptfor additive electronics machines in Europe: As a result of the Russia-Ukraine war, our revenues in Russia and Poland were reduced in the first 9 months of 2022 by approximately $1.5M (75%) compared to the same period in 2021. Additionally, we understand from other customers there that the continued components’ supply chainshortages have caused them to request a delay in delivery of additive electronic machines (which are used to mount those delayed components).

Sales and deliveries in the USA of similar machines grew organically by 45% over the 9 months ended September 30th, 2022, compared to the similar period in 2021.  

The Gross Margin is a bit lower than we have anticipated, which is a result of the above mentioned held-back deliveries in Europe without reducing the fixed manufacturing overhead. The inherent gross margin of that technology is above 30%, as it has been for years, and it is within the typical range for that industry segment. We sold 69 machines of this kind since 1-1-2022. The Q3/2022 lower gross margin is also a result of trading up old AME machines with new ones, which are transactions at lower gross margins than the regular new AME machine sales.” 

FINANCIAL RESULTS:

Third Quarter 2022 Financial Results

  • Total revenues for the third quarter of 2022 were $9,998,000, compared to $11,101,000 in the second quarter of 2022, and $1,340,000 in the third quarter of 2021. The decrease compared to the second quarter of 2022 was influenced by the conflict in Europe and supply chain delays, as explained above. The increase compared to the third quarter of 2021 is attributed to increased sales of the Company’s product lines.

  • Cost of revenues (excluding amortization of intangibles) for the third quarter of 2022 was $7,428,000, compared to $7,151,000 in the second quarter of 2022, and $696,000 in the third quarter of 2021. The increase is attributed mostly to the increased sales of the Company’s product lines.

  • Research and development (R&D) expenses for the third quarter of 2022 were $18,535,000, compared to $18,365,000 in the second quarter of 2022, and $13,726,000 in the third quarter of 2021. The increase compared to the second quarter of 2022 is attributed to an increase in materials and subcontractors’ expenses, as well as an increase in depreciation expenses, partially offset by a decrease in share-based payment expenses. The increase compared to the third quarter of 2021 is attributed mainly to an increase in payroll expenses and subcontractors expenses and is partially offset by a decrease in depreciation and share-based payment expenses.

    • The R&D expenses includes depreciation and share-based payments expenses of $5,057,000.

  • Sales and marketing (S&M) expenses for the third quarter of 2022 were $9,652,000, compared to $10,115,000 in the second quarter of 2022, and $6,301,000 in the third quarter of 2021. The decrease compared to the second quarter of 2022 is attributed mainly to the decrease in marketing and share-based payment expenses, partially offset by an increase in payroll expenses. The increase compared to the third quarter of 2021 is attributed mainly to an increase in payroll and marketing related expenses as well as an increase in depreciation, partially offset by a decrease in share-based payment expenses.

    • The S&M expenses includes depreciation and share-based payments expenses of $1,941,000.

  • General and administrative (G&A) expenses for the third quarter of 2022 were $7,417,000, compared to $7,207,000 in the second quarter of 2022, and $4,843,000 in the third quarter of 2021. The increase compared to the third quarter of 2021 is attributed to an increase in payroll and professional services due to the Company’s latest acquisitions, as well as an increase in office expenses.

    • The G&A expenses includes depreciation and share-based payments expenses of $1,604,000.

  • Net loss attributed to the owners for the third quarter of 2022 was $66,931,000, or $0.26 per share, compared to $39,732,000, or $0.15 per share, in the second quarter of 2022, and $18,237,000 or $0.07 per share, in the third quarter of 2021.

    • Adjusted EBITDA for the 3rd quarter of 2022 was negative $24.2M, excluding $42.9M of non-cash adjustments for finance expenses/income for revaluation of assets and liabilities, share-based payments, exchange rate differences, and depreciation and amortization expenses.

Nine Months Ended September 30 2022, Financial Results

  • Total revenues for the nine months period ended September 30th, 2022, were $31,529,000, compared to $2,962,000 in the nine months period ended September 30th, 2021. The increase is attributed to increased sales of the Company’s product lines.

  • Cost of revenues (excluding amortization of intangibles) for the nine months period ended September 30th, 2022, was $21,159,000, compared to $1,380,000 in the nine months period ended September 30th, 2021. The increase is attributed mostly to increased sales of the Company’s product lines.

  • R&D expenses for the nine months period ended September 30th, 2022, were $54,770,000, compared to $26,587,000 in the nine months period ended September 30, 2021. The increase is attributed to an increase in payroll and subcontractors’ expenses as well as an increase in share-based payment expenses, as a result of the Company’s increased R&D efforts.

    • The R&D expenses for the nine months period ended September 30th, 2022 includes depreciation and share-based payments expenses of $16,625,000.

  • S&M expenses for the nine months period ended September 30, 2022, were $29,075,000, compared to $15,023,000 in the nine months period ended September 30, 2021. The increase is attributed to an increase in payroll and marketing expenses as well as an increase in share-based payment expenses as a result of the Company’s growing sales and marketing team.

    • The S&M expenses for the nine months period ended September 30th, 2022 includes depreciation and share-based payments expenses of $7,682,000.

  • G&A expenses for the nine months period ended September 30th, 2022, were $21,366,000, compared to $13,174,000 in the nine months period ended September 30th, 2021. The increase is attributed to an increase in payroll expenses as well as an increase in office and rent and related expenses, and professional services.

    • The G&A expenses for the nine months period ended September 30th, 2022 includes depreciation and share-based payments expenses of $4,962,000.

  • Net loss attributed to the owners for the nine months period ended September 30th, 2022, was $139,756,000, or $0.54 per share, compared to $41,153,000, or $0.17 per share, in the nine months period ended September 30th, 2021.

    • Adjusted EBITDA for the nine months period ended September 30th, 2022 was negative $64.7M, excluding $76.5M of non-cash adjustments for finance expenses/income for revaluation of assets and liabilities, share-based payments, exchange rate differences, and depreciation and amortization expenses.

Balance Sheet Highlights

  • Cash and cash equivalents, together with short and long-term unrestricted bank deposits totaled $1,048,712,000 as of September 30th, 2022, compared to $1,355,595,000 as of December 31st, 2021. The decrease compared to December 31st, 2021, mainly reflects cash used in operating activities and investing activities.

  • Shareholders’ equity totaled $1,230,716,000 as of September 30th, 2022, compared to $1,343,356,000 as of December 31st, 2021.

Conference call information

The Company will host a conference call to discuss these financial results today, December 1st, 2022, at 9:00 a.m. EDT (4:00 p.m. IDT).
We encourage participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10172491/f4dc959048.
Webcast link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=dJL0SDBd.
U.S. Dial-in Number: 844-695-5517, INTERNATIONAL DIAL IN: 1-412-902-6751, Israel Dial-in Number: 1-80-9212373. Please request the “Nano Dimension NNDM call” when prompted by the conference call operator. For those unable to participate in the conference call, there will be a replay available from a link on Nano Dimension’s website at http://investors.nano-di.com/events-and-presentations.

About Nano Dimension
Nano Dimension’s (Nasdaq: NNDM) vision is to transform the  electronics and similar additive manufacturing sectors  through the development and delivery of an environmentally friendly and economically efficient additive manufacturing, Industry 4.0 solution, while enabling a  one-production-step-conversion  of digital designs into functioning devices – on demand, anytime, anywhere.                    

The  DragonFly IV ®  system and specialized materials serve cross-industry  H igh- P erformance- E lectronic- D evice s  ( Hi-PEDs ® ) fabrication needs by simultaneously depositing proprietary conductive and dielectric substances, while integrating in-situ capacitors, antennas, coils, transformers, and electromechanical components. The outcomes are Hi-PEDs® which are critical enablers of autonomous intelligent drones, cars, satellites, smartphones, and in vivo medical devices. In addition, these products enable iterative development, IP safety, fast time-to-market, and device performance gains. 

Nano Dimension also develops complementary production equipment for  Hi-PEDs ®  and printed circuit board (PCB) assembly ( Puma, Fox, Tarantula, Spider  etc.). The core competitive edge for this technology is in its adaptive, highly flexible surface-mount technology (SMT) pick-and-place equipment, materials dispenser suitable for both high-speed dispensing and micro-dispensing, as well as an intelligent production material storage and logistics system.  Nano Dimension is a leading developer and supplier of high-performance control electronics, software, and ink delivery system. It invents and delivers state-of-the-art 2D and 3D printing hardware and unique operating software.  It focuses on high-value, precision-oriented applications such as specialized direct-to-container packaging, printed electronics functional fluids, and 3D printing, all controlled by the proprietary software system - Atlas.

Serving similar users of  Hi-PEDs ® , Nano Dimension’s  AM products include Fabrica 2.0  micro additive manufacturing system enables the production of microparts based on a Digital Light Processor (DLP) engine that achieves repeatable micron levels resolution. In addition, Nano’s Admatec Division supplies printing from Powder to Part by powder-based shaping & sintering technologies , from design to serial production of Powder Metallurgical & Ceramic parts or devices. The Admaflex 130 & 300 3D printing machines for ceramics and metals are modular DLP printing systems on one platform with customer-friendly software enabling full parameter accessibility & control and unique vision-based process monitoring.  

For more information, please visit www.nano-di.com.

Forward-Looking Statements  
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on Nano Dimension’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Nano Dimension could differ materially from those described in or implied by the statements in this press release. For example, Nano Dimension is using forward-looking statements when it discusses the potential for growth of approximately 300% in full year 2022 and 10 times from 2020 to 2022, the ability of the Company to execute on its vision and business plans, including without needing to raise more capital, its future growth both organically and from acquisitions, its ability to sell complementary products, its commitment, vision and aim to build an ecofriendly and intelligent distributed secured network of 3D printers & roll-in adjacent industrial machine-learning-led-digitized manufacturing and self-learning and self-improving machines, that if contraction of multiples and valuations will be sustained, the Company expects to take advantage of its frugal approach to cash management during the unreasonable “market-inflation” during 2020 to early 2022, and that if acquisitions will withstand more reasonable prices, the Company hopes to show attractive synergistic growth from M&A activity. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Nano Dimension’s Annual Report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on March 31, 2022, and in any subsequent filings with the SEC. Except as otherwise required by law, Nano Dimension undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Nano Dimension is not responsible for the contents of third-party websites. 

NANO DIMENSION INVESTOR RELATIONS CONTACT

Yael Sandler, CFO | ir@nano-di.com 



Unaudited Consolidated Statements of Financial Position as at

    September 30,     December 31  
(In thousands of USD)   2021     2022     2021(*)  
    (Unaudited)     (Unaudited)        
Assets                
Cash and cash equivalents     1,127,778       370,197       853,626  
Bank deposits     257,613       650,111       437,598  
Restricted deposits     165       77       148  
Trade receivables     1,223       5,929       3,422  
Other receivables     3,459       2,925       5,902  
Inventory     4,035       17,837       11,199  
Total current assets     1,394,273       1,047,076       1,311,895  
                       
Restricted deposits     483       521       501  
Bank deposits     -       28,404       64,371  
Investment in securities     -       139,707       -  
Other long-term assets     -       1,282       1,007  
Property plant and equipment, net     7,523       13,166       7,690  
Right of use asset     4,869       13,972       4,491  
Intangible assets     116,767       31,799       -  
Total non-current assets     129,642       228,851       78,060  
Total assets     1,523,915       1,275,927       1,389,955  
                       
Liabilities                      
Trade payables     1,796       2,925       2,833  
Financial derivatives     4,775       8,189       14,910  
Other payables     7,970       18,864       13,836  
Current portion of other long-term liability     -       370       417  
Total current liabilities     14,541       30,348       31,996  
                       
Liability in respect of government grants     1,910       1,507       1,560  
Employee benefits     -       296       4,145  
Liability in respect of warrants     5,523       124       3,347  
Lease liability     3,577       10,519       3,336  
Deferred tax liabilities     3,128       587       236  
Loan from banks     -       785       1,104  
Other long-term liabilities     -       180       -  
Total non-current liabilities     14,138       13,998       13,728  
Total liabilities     28,679       44,346       45,724  
                       
Equity                      
Non-controlling interests     572       865       875  
Share capital     386,372       387,646       386,665  
Share premium and capital reserves     1,257,980       1,291,290       1,266,027  
Treasury shares     (1,509 )     (1,509 )     (1,509 )
Remeasurement of Net Defined Benefit liability (IAS 19)     -       3,127       -  
Presentation currency translation reserve     1,431       (848 )     1,407  
Accumulated loss     (149,610 )     (448,990 )     (309,234 )
Equity attributable to owners of the company     1,494,664       1,230,716       1,343,356  
Total equity     1,495,236       1,231,581       1,344,231  
Total liabilities and equity     1,523,915       1,275,927       1,389,955  
(*) The December 31st , 2021, balances were derived from the Company’s audited annual financial statements.



Unaudited Consolidated Statements of Profit or Loss and Other Comprehensive Income

(In thousands of USD, except per share amounts)
  

    For the Nine-Month
Period Ended
September 30,
    For the Three-Month
Period Ended
September 30,
    For the Year ended
December 31
 
    2021     2022     2021     2022     2021(*)  
    (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)        
                               
Revenues   2,962     31,529     1,340     9,998     10,493  
                                         
Cost of revenues     1,380       21,159       696       7,428       5,730  
                                         
Cost of revenues - amortization of inventory and assets recognized in business combination and technology     772       3,990       281       771       3,641  
                                         
Total cost of revenues     2,152       25,149       977       8,199       9,371  
                                         
Gross profit     810       6,380       363       1,799       1,122  
                                         
Research and development expenses, net     26,587       54,770       13,726       18,535       41,686  
                                         
Sales and marketing expenses     15,023       29,075       6,301       9,652       22,713  
                                         
General and administrative expenses     13,174       21,366       4,843       7,417       19,644  
                                         
Impairment losses     -       -       -       -       140,290  
                                         
Operating loss     (53,974 )     (98,831 )     (24,507 )     (33,805 )     (223,211 )
                                         
Finance income     13,065       13,826       6,036       7,001       17,909  
                                         
Finance expense     910       56,132       282       40,282       428  
                                         
Loss before taxes on income     (41,819 )     (141,137 )     (18,753 )     (67,086 )     (205,730 )
Tax income (expense)     648       742       498       (47     4,906  
Total loss after tax     (41,171 )     (140,395 )     (18,255 )     (67,133 )     (200,824 )
Total loss attributable to:                                        
Non-controlling interests     (18 )     (639 )     (18 )     (202 )     (47 )
Owners of the Company     (41,153 )     (139,756 )     (18,237 )     (66,931 )     (200,777 )
                                         
Basic loss per share     (0.17 )     (0.54 )     (0.07 )     (0.26 )     (0.81 )
                                         
Other comprehensive income items that after initial recognition in comprehensive income were or will be transferred to profit or loss                                        
                                         
Foreign currency translation differences for foreign operations     -       (2,351 )     -       (1,113 )     (46 )
Remeasurement of net defined benefit liability (IAS 19), net of tax     -       3,127       -       -       -  
Total comprehensive loss     (41,171 )     (139,619 )     (18,255 )     (68,246 )     (200,870 )
Comprehensive loss attributable to non-controlling interests     -       (735 )     -       (247 )     (69 )
Comprehensive loss attributable to owners of the Company     (41,171 )     (138,884 )     (18,255 )     (67,999 )     (200,801 )
                                         
(*)  The December 31st, 2021, balances were derived from the Company’s audited annual financial statements.  



Consolidated Statements of Changes in Equity (Unaudited)
(In thousands of USD)

        Share       Foreign                  
        premium       currency           Non-      
    Share   and capital   Treasury   translation   Accumulated       controlling   Total  
    capital   reserves   shares   reserve   loss   Total   interests   equity  
For the nine months ended September 30, 2022:   Thousands
USD
  Thousands
USD
  Thousands
USD
  Thousands
USD
  Thousands
USD
  Thousands
USD
  Thousands
USD
  Thousands
USD
 
Balance as of January 1, 2022   386,665   1,266,027   (1509 ) 1,407   (309,234 ) 1,343,356   875   1,344,231  
Investment of non-controlling party in subsidiary   -   -   -   -   -   -   725   725  
Loss for the period   -   -   -   -   (139,756 ) (139,756 ) (639 ) (140,395 )
Other comprehensive loss for the year, net of tax   -   3,127   -   (2,255 ) -   872   (96 ) 776  
Exercise of options   981   (981 ) -   -   -   -   -   -  
Share-based payment acquired   -   (744 ) -   -   -   (744 ) -   (744 )
Share-based payments   -   26,988   -   -   -   26,988   -   26,988  
Balance as of September 30, 2022   387,646   1,294,417   (1509 ) -848   (448,990 ) 1,230,716   865   1,231,581  

 

 

Consolidated Statements of Changes in Equity (Unaudited)
(In thousands of USD)

        Share       Foreign                  
        premium       currency           Non-      
    Share   and capital   Treasury   translation   Accumulated       controlling   Total  
    capital   reserves   shares   reserve   loss   Total   interests   equity  
For the three months ended September 30, 2022:   Thousands
USD
  Thousands
USD
  Thousands
USD
  Thousands
USD
  Thousands
USD
  Thousands
USD
  Thousands
USD
  Thousands
USD
 
Balance as of June 30, 2022   387,312   1,287,451   (1509 ) 220   (382,059 ) 1,291,415   553   1,291,968  
Investment of non-controlling party in subsidiary   -   -   -   -   -   -   559   559  
Loss for the period   -   -   -   -   -66,931   (66931 ) (202 ) (67,133 )
Other comprehensive loss for the year, net of tax   -   -   -   (1068 ) -   (1068 ) (45 ) (1113 )
Exercise of options   334   (334 ) -   -   -   -   -   -  
Share-based payment acquired   -   -   -   -   -   -   -   -  
Share-based payments   -   7,300   -   -   -   7,300   -   7,300  
Balance as of September 30, 2022   387,646   1,294,417   (1509 ) (848 ) (448,990 ) 1,230,716   865   1,231,581  



Consolidated Statements of Cash Flows (Unaudited)
(In thousands of USD)

    For the
Nine-Month Period
Ended September 30 th ,
    For the
Three-Month Period
Ended September 30th,
    For the Year
ended
December 31st,
 
    2021     2022     2021     2022     2021(*)  
Cash flow from operating activities:                              
Net loss     (41,171 )     (140,395 )     (18,255 )     (67,133 )     (200,824 )
Adjustments:                                        
Depreciation and amortization     4,978       6,084       2,392       3,228       7,383  
Impairment losses     -       -       -       -       140,290  
Financing expenses (income), net     (1,799 )     9,089       (499 )     (3,466 )     (6,873 )
Revaluation of financial liabilities accounted at fair value     (10,356 )     (4,851 )     (5,255 )     (1,934 )     (10,608 )
Loss from disposal of property plant and equipment and right-of-use assets     72       91       30       97       567  
Increase in deferred tax     (734 )     (1,441 )     (499 )     (109 )     (5,013 )
Revaluation of financial assets accounted at fair value     -       38,068       -       38,681       -  
Share-based payments     21,503       26,637       10,186       7,300       29,782  
Salary expenses paid by non-controlling interest (NCI)     -       216       -       50       -  
      13,664       73,893       6,355       43,847       155,528  
Changes in assets and liabilities:                                        
Decrease (increase) in inventory     (591 )     (3,384 )     85       (1,506 )     2,382  
Decrease (increase) in other receivables     (9 )     3,574       (130 )     3,871       (429 )
Decrease (increase) in trade receivables     (510 )     (1,761 )     (371 )     198       (449 )
Increase (decrease) in other payables     (70 )     1,333       836       (64 )     1,139  
Increase (decrease) in employee benefits     -       1,101       -       (635 )     -  
Increase (decrease) in trade payables     629       (42 )     218       (881 )     74  
      (551 )     821       638       983       2,717  
                                         
Net cash used in operating activities     (28,058 )     (65,681 )     (11,262 )     (22,303 )     (42,579 )
                                         
Cash flow from investing activities:                                        
Investment in bank deposits and loans, net     (171,929 )     (187,412 )     104,490       (140,921 )     (416,019 )
Interest received     2,621       4,634       910       2,143       3,706  
Change in restricted bank deposits     (31 )     (16 )     (3 )     59       (32 )
Acquisition of property plant and equipment     (2,165 )     (6,059 )     (1,150 )     (1,520 )     (9,761 )
Payment of a liability to pay a contingent consideration of business combination     -       (10,708 )     -       (709 )     -  
Investment in shares measured in fair value through profit and loss     -       (177,775 )     -       (159,972 )     -  
Acquisition of subsidiary, net of cash acquired     (62,644 )     (31,058 )     -       (12,899 )     (74,574 (
                                         
Net cash used in investing activities     (234,148 )     (408,394 )     104,247       (313,819 )     (496,680 )
                                         
Cash flow from financing activities:                                        
Proceeds from issuance of Ordinary Shares, warrants and convertible notes, net     805,497       -       -       -       805,497  
Exercise of warrants and options     150       -       -       -       212  
Lease payments     (1,246 )     (3,088 )     (445 )     (1,207 )     (1,494 )
Proceeds from non-controlling interests     590       510       590       510       944  
Repayment of long-term bank debt     -       (303 )     -       (85 )     (814 )
Amounts recognized in respect of government grants liability, net     (7 )     (132 )     (35 )     (39 )     (96 )
Share-based payment acquired     -       (744 )     -       -       -  
Interest and other fees paid     (5 )     (95 )     22       (42 )     (70 )
Net cash provided by financing activities     804,979       (3,852 )     132       (863 )     804,179  
Increase in cash     542,773       (477,927 )     93,117       (336,985 )     264,920  
Cash at beginning of the period     585,338       853,626       1,034,838       706,220       585,338  
Effect of exchange rate fluctuations on cash     (333 )     (5,502 )     (177 )     962       3,368  
Cash at end of the period     1,127,778       370,197       1,127,778       370,197       853,626  
                                         
Non-cash transactions:                                        
Property plant and equipment acquired on credit     102       509       75       474       249  
Conversion of convertible notes and warrants to equity     2,830       -       -       -       2,830  
Acquisition of a right-of-use asset     1,890       11,536       90       286       1,919  
Acquisition of financial assets in fair value through profit and loss against credit received     -       -       -       (2,158     -  
                                         
(*)  The December 31st, 2021, balances were derived from the Company’s audited annual financial statements.  

 

 

Non-IFRS measures

The following is a reconciliation of EBITDA and Adjusted EBITDA to loss before taxes, as calculated in accordance with International Financial Reporting Standards (“IFRS”):

    For the
Nine -Month
Period Ended
September 30th,
    For the
Three-Month
Period Ended
September 30th,
 
    2022  
    In thousands of USD  
Loss before taxes on income     (141,137 )     (67,086 )
Depreciation and amortization (*)     7,617       2,345  
Interest expense (income)     (8,962 )     (4,715 )
EBITDA (loss)     (142,482 )     (69,456 )
Finance expense for revaluation of assets and liabilities     33,368       36,535  
Exchange rate differences     17,805       1,420  
Share-based payments     26,637       7,300  
Adjusted EBITDA (loss)     (64,672 )     (24,201 )
                 
Gross profit     6,380       1,799  
Amortization of inventory and intangibles     3,990       771  
Adjusted gross profit, excluding amortization of intangible assets     10,370       2,570  


(*) Including amortization of assets recognized in business combination and technology

EBITDA is a non-IFRS measure and is defined as total comprehensive loss before taxes excluding depreciation and amortization expenses and amortization of assets recognized in business combination and interest expense or income. We believe that EBITDA, as described above, should be considered in evaluating the Company’s operations. EBITDA facilitates the Company’s performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures, and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), and EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to the items mentioned above.

Adjusted EBITDA is a non-IFRS measure and is defined as total comprehensive loss before taxes excluding depreciation and amortization expenses and amortization of assets recognized in business combination, interest expenses or income, finance expense (income) for revaluation of assets and liabilities, exchange rate differences and share-based payments. We believe that Adjusted EBITDA, as described above, should also be considered in evaluating the Company’s operations. Like EBITDA, Adjusted EBITDA facilitates the Company’s performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures, and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), as well as from revaluation of assets and liabilities, exchange rate differences and share-based payment expenses. Adjusted EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to non-cash items, such as expenses related to revaluation, exchange rate differences and share-based payments.

Adjusted gross profit, excluding amortization of inventory and intangibles, is a non-IFRS measure and is defined as gross profit excluding amortization expenses. We believe that adjusted gross profit, as described above, should also be considered in evaluating the Company’s operations. Adjusted gross profit facilitates gross profit and gross margin comparisons from period to period and company to company by backing out potential differences caused by variations in amortization of inventory and intangible assets. Adjusted gross profit is useful to an investor in evaluating our performance because it enables investors, securities analysts and other interested parties to measure a company’s performance without regard to non-cash items, such as amortization expenses.

EBITDA, Adjusted EBITDA, and adjusted gross profit do not represent cash generated by operating activities in accordance with IFRS and should not be considered alternatives to net income (loss) as indicators of our operating performance or as measures of our liquidity. These measures should be considered in conjunction with net income (loss) as presented in our consolidated statements of profit or loss and other comprehensive income. Other companies may calculate these measures differently than we do.


Primary Logo

Source: Nano Dimension Ltd.

View all news